Clinical Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line Maintenance Therapy for Epithelial Ovarian Cancer
Clinical trial NCT07779538 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07779538
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-01
- Primary completion
- 2030-02-28
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.